Liminatus Pharma, Inc. (NASDAQ:LIMN), a $226.59 million market cap company whose stock has surged over 56% in the past week according to InvestingPro data, announced Monday plans to establish a subsidiary called American BNB Strategy focused on investing up to $500 million in $BNB coin, the native token of the Binance ecosystem.
